Ontology highlight
ABSTRACT: Background
Myocardial infarction (MI) is a leading cause of death worldwide. Therefore, nanoparticles that applied for specific diagnosis of the infarcted area and/or local myocardial delivery of therapeutic agents, are highly desired.Materials and methods
Herein, we developed the MnO-based nanoparticles, with magnetic resonance (MR) and near-infrared fluorescence imaging modalities as an MR imaging contrast agent and potential drug vehicle for the detection and treatment of MI. The chemophysical characteristics, targeting ability toward infarcted myocardium, biodistribution, and biocompatibility of the MnO-based nanoparticles were studied.Results
It was found that the MnO-based dual-modal nanoparticles possess high r 1 relaxivity and induced no no
SUBMITTER: Zheng Y
PROVIDER: S-EPMC6181115 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature